Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diversa Corporation (DVSA) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (101)	2/14/2005 7:12:12 AM
From: nigel bates	Read Replies (1) \| Respond to of 144

Diversa Achieves Milestone Under Syngenta Agreement for Delivery of Product Candidates (Results due Thursday.) SAN DIEGO, Feb. 14 /PRNewswire-FirstCall/ -- Diversa Corporation (Nasdaq: DVSA - News) today announced that it has achieved an important product development milestone under its research and development agreement with Syngenta AG (NYSE: SYT - News), corresponding to a milestone payment of $500,000. Diversa successfully delivered to Syngenta multiple qualified enzyme candidates for use as animal feed additives. "This milestone is an excellent example of Diversa's ability to rapidly develop novel enzymes directed at improving the utility of animal feed," stated Jay M. Short, Ph.D., Diversa's President and Chief Executive Officer. "These product candidates are part of our ongoing efforts to build a high-value portfolio of animal nutrition products with our partner Syngenta." "We are pleased with the results Diversa has achieved by developing novel enzyme products to satisfy unmet needs in animal feed and nutrition," said Dr. David Jones, Head of Business Development for Syngenta. "This milestone enables Syngenta to move another product forward in our growing portfolio of animal feed enzymes."...